NASDAQ: WVEWave Life Sciences Ltd Stock Ownership - Who owns Wave Life Sciences?
Insider buying vs selling
Have Wave Life Sciences Ltd insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2026-02-26 | 17,900 | $3.87 | $69.27kBuy |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2026-02-26 | 17,900 | $15.09 | $270.18kSell |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2026-02-26 | 15,294 | $4.75 | $72.65kBuy |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2026-02-26 | 15,294 | $15.00 | $229.41kSell |
| Kyle Moran | Chief Financial Officer | 2026-02-09 | 3,588 | $13.45 | $48.26kSell |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2026-02-09 | 1,883 | $13.45 | $25.33kSell |
| Chandra Vargeese | Chief Technology Officer Head of Platform Discovery Sciences | 2026-02-09 | 3,228 | $13.45 | $43.42kSell |
| Paul Bolno | President and CEO | 2026-02-09 | 10,480 | $13.45 | $140.96kSell |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2026-01-02 | 9,375 | $3.14 | $29.44kBuy |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2026-01-02 | 1,295 | $16.70 | $21.63kSell |
WVE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when WVE insiders and whales buy or sell their stock.
WVE Shareholders
What type of owners hold Wave Life Sciences Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gsk PLC | 15.37% | 28,929,452 | $397.78M | Insider |
| Gsk PLC | 9.69% | 18,245,691 | $250.88M | Institution |
| Ra Capital Management LP | 9.67% | 18,203,009 | $250.29M | Institution |
| Fmr LLC | 8.04% | 15,135,983 | $208.12M | Institution |
| Blackrock Inc | 6.72% | 12,648,907 | $173.92M | Institution |
| Adage Capital Partners GP LLC | 5.20% | 9,786,061 | $134.56M | Institution |
| Maverick Capital Ltd | 4.93% | 9,280,237 | $127.60M | Institution |
| Ken Takanashi | 4.10% | 7,713,133 | $106.06M | Insider |
| Ra Capital Management LP | 4.04% | 7,602,428 | $104.53M | Insider |
| Price T Rowe Associates Inc | 3.93% | 7,407,372 | $101.85M | Institution |
WVE vs Biotech Stocks
Wave Life Sciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.